Catalent, Triphase Partner to Advance Antibody Drug Conjugate
By
Catalent has entered into an agreement with Triphase Accelerator Corporation, a Toronto-based company acquiring and developing cancer therapeutics, in which Triphase will obtain worldwide rights to further develop Catalent’s proprietary…
ABEC Completes Bulk Biologics Installation at Regeneron Facility
By
ABEC, a Bethlehem, Pennsylvania-based engineering, equipment, and services provider, has completed the installation of a bulk biologics manufacturing process in Regeneron Pharmaceuticals’ site in Raheen, County Limerick, Ireland. The first…